Gastrointestinal symptoms are associated with a lower risk of hospitalization and mortality and outcomes in COVID-19

Table 1 Comparison demographic and health variables according to different symptoms subgroups

	Total (n = 42,964)	Group 1 (n = 1572)	Group 2 (n = 28,940)	Group 3 (n = 2615)	Group 4 (n = 9837)	P value
Age, years	51.36 ± 19.61	47.50 ± 22.36	52.42 ± 19.24	54.43 ± 19.28	48.02 ± 19.85	0.001
Gender						0.001
Women	20,110 (46.8)	813 (51.7)	13,359 (46.1)	1241 (47.46)	4697 (47.75)
Men	22,854 (53.2)	759 (49.3)	15,581 (43.9)	1374 (52.54)	5140 (52.25)
Cigarette smoking, yes	686(1.60)	26(1.65)	459(1.58)	89(3.40)	112(1.13)	0.001
Drug abuse, yes	351(0.82)	16(1.44)	227(0.78)	43(1.64)	65(0.66)	0.001

Continuous variables were reported as mean ± standard deviations (SD), and qualitative variables were reported as frequency (%). A one-way ANOVA test was used to explore differences between the symptoms subgroups. To comparison of qualitative variables between four groups, the Chi-square test was used
Group 1: Patients with Gastrointestinal symptoms; Group 2: Patients with respiratory symptoms; Group 3: Patients with both symptoms: Group 4: Patients with other symptoms
*Among hospitalized patients only (n = 22,162)

ISSN: 1471-230X